Celltrion vs Samsung Biologics: Which Samsung Is Actually the Competitor?
English coverage of Korean biologics keeps pairing two names: Celltrion and Samsung. Headlines describe a “duel” and a race for […]
Bio
Korean biotech and pharma โ Samsung Biologics, LigaChem Bio, SK Biopharmaceuticals, and the next wave of K-Bio innovation.
Celltrion (068270): It Promised to Cancel 4% of Itself, Delivered โ and the Share Count Went Up
In March 2026 a Korean biotech told its shareholders, in a regulatory filing that has no English counterpart, that it
LigaChem Bio Stock: Korea’s ADC Out-Licensing Machine (2026 Deep Dive)
A Korean confectionery giant now controls one of the world’s busiest antibody-drug conjugate labs. LigaChem Bio has licensed its cancer-drug
Samsung Biologics Valuation: CDMO Super-capacity and Biosecure Act Tailwind
๐ Global Growth: Record-breaking export volume driven by aggressive global expansion. ๐ Valuation Moat: Significant discount compared to global peers